World Vaccine Congress Europe
World Vaccine Congress Europe

 

2024 Speakers

28-31 October,  2024
Barcelona

 

Jeffrey Almond, Former VP Discovery R&D, Sanofi & Visiting Professor, University of Oxford - Oxford Vaccine Group

Jeffrey Almond | Former VP Discovery R&D, Sanofi & Visiting Professor | University of Oxford - Oxford Vaccine Group » speaking at Vaccine Congress Europe

Galit Alter, VP of Immunology Research, Moderna

Galit Alter | VP of Immunology Research | Moderna » speaking at Vaccine Congress Europe

Montserrat Arroyo, Deputy Director General for International Standards and Science, WOAH

Montserrat Arroyo | Deputy Director General for International Standards and Science | WOAH » speaking at Vaccine Congress Europe

Francesco Berlanda Scorza, Director GVGH, GSK Vaccines for Global Health (GVGH)

Francesco Berlanda Scorza | Director GVGH | GSK Vaccines for Global Health (GVGH) » speaking at Vaccine Congress Europe

Cedric Bogaert, Chief Executive Officer, MYNEO NV

Maria Elena Bottazzi, Co-Director of Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine

Maria Elena Bottazzi | Co-Director of Texas Children's Hospital Center for Vaccine Development | Baylor College of Medicine » speaking at Vaccine Congress Europe

Michael Caldwell, Assoc VP Vaccine Research & Education, Meharry Medical College

Miles Carroll, Head of High Consequence Emerging Viruses Group, Pandemic Sciences Institute, University of Oxford

Miles Carroll | Head of High Consequence Emerging Viruses Group, Pandemic Sciences Institute | University of Oxford » speaking at Vaccine Congress Europe

Andrew Catchpole, CSO, hVIVO

Mr Ajoy Chakrabarti, Portfolio And Platform Lead, The Bill & Melinda Gates Foundation

Mr Ajoy Chakrabarti | Portfolio And Platform Lead | The Bill & Melinda Gates Foundation » speaking at Vaccine Congress Europe

Roman Chicz, Global Head Of External Research And Development, Sanofi

Roman Chicz | Global Head Of External Research And Development | Sanofi » speaking at Vaccine Congress Europe

Dennis Christensen, Head of Global R&D, Croda

Chad Costley, Chief Executive Officer, BlueWillow Biologics, Inc.

Jakob Cramer, Head Of Clinical Development, CEPI

Jakob Cramer | Head Of Clinical Development | CEPI » speaking at Vaccine Congress Europe

Helge Dorfmuller, Principal Investigator, University of Dundee

Helge Dorfmuller | Principal Investigator | University of Dundee » speaking at Vaccine Congress Europe

Mark Emalfarb, Chief Executive Officer, Dyadic International Inc

Dr. Aaron Esser-Kahn, Professor, University of Chicago

Katie Ewer, Senior Project Leader, GSK

Antonio Garcia Maldonado, Investment Professional, Strategic Investment Fund, Bill and Melinda Gates Foundation

Cyril Gay, Senior National Program Leader, A.R.S. National Programs

Cyril Gay | Senior National Program Leader | A.R.S. National Programs » speaking at Vaccine Congress Europe

Marion Gruber, Vice President of Public Health and Regulatory Affairs, IAVI

Andrea Guerra, Regional Clinical Director Vaccines - Europe, MSD

Andrea Guerra | Regional Clinical Director Vaccines - Europe | MSD » speaking at Vaccine Congress Europe

Bassam Hallis, Deputy Director, Research and Evaluation, UK Health Security Agency

Bassam Hallis | Deputy Director, Research and Evaluation | UK Health Security Agency » speaking at Vaccine Congress Europe

Ali M Harandi, Lab Head, Dpt Of Microbiology And Immunology, University of Gothenburg

Mateusz Hasso-Agopsowicz, Technical Officer, World Health Organization

Mateusz Hasso-Agopsowicz | Technical Officer | World Health Organization » speaking at Vaccine Congress Europe

Dr Mark Howarth, Sheild Chair of Pharmacology, University Of Cambridge

Hans Keirstead, Chief Executive Officer, AIVITA Biomedical, Inc.

Edward Kelley, Chief Global Health Officer, ApiJect

Jerome Kim, Director General, IVI

Jerome Kim | Director General | IVI » speaking at Vaccine Congress Europe

Alexandre Le Vert, Chief Executive Officer, Osivax

Geert Leroux Roels, Professor Emeritus, Gent University

Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital

Lenny Moise, VP, Research, SeromYx

Hanna Nohynek, Chief Physician, National Institute for Health and Welfare

Ab Osterhaus, Director of Research Center For Emerging Infections and Zoonoses and Professor, University of Veterinary Medicine Hannover

Ab Osterhaus | Director of Research Center For Emerging Infections and Zoonoses and Professor | University of Veterinary Medicine Hannover » speaking at Vaccine Congress Europe

Serge Pampfer, Chief Executive Officer, LoValtech

Serge Pampfer | Chief Executive Officer | LoValtech » speaking at Vaccine Congress Europe

Francesco Pappalardo, Deputy Director, Department of Drug and Health Sciences, University of Catania

Dr Robert Paris, VP, Therapeutic Area Head, Latent Viruses, Moderna

Dr Robert Paris | VP, Therapeutic Area Head, Latent Viruses | Moderna » speaking at Vaccine Congress Europe

Shanti Pather, Senior Global Medical Affairs Director, Vaccines, BioNTech SE

Haiko Pillu, Director Operations CPU, SGS

Jan Poolman, Head Bacterial Vaccine Discovery and Early Development, Janssen

Jan Poolman | Head Bacterial Vaccine Discovery and Early Development | Janssen » speaking at Vaccine Congress Europe

Ruben Rizzi, SVP Global Regulatory Affairs, BioNTech SE

Cesar Sanz Rodriguez, Vice President, Medical Affairs - Europe, Middle East & Africa, Moderna

Cesar Sanz Rodriguez | Vice President, Medical Affairs - Europe, Middle East & Africa | Moderna » speaking at Vaccine Congress Europe

Jerald Sadoff, Chief Medical Officer, Centivax

Dr Jeremy Salt, Chief Executive Officer, The Vaccine Group

Dr Jeremy Salt | Chief Executive Officer | The Vaccine Group » speaking at Vaccine Congress Europe

Matthew Snape, VP, Clinical Development, Paediatric and Maternal Vaccines & Visiting Professor, Department of Paediatrics, University of Oxford, Moderna

Matthew Snape | VP, Clinical Development, Paediatric and Maternal Vaccines & Visiting Professor, Department of Paediatrics, University of Oxford | Moderna » speaking at Vaccine Congress Europe

Walter Straus, Vice President, Clinical Safety & Risk Management, Moderna Therapeutics

Nigel Temperton, Professor, University of Kent

Joris Vandeputte, President, IABS

Joris Vandeputte | President | IABS » speaking at Vaccine Congress Europe

Carla Vinals, VP Head of Regulatory Strategy, Moderna

Carla Vinals | VP Head of Regulatory Strategy | Moderna » speaking at Vaccine Congress Europe

Dr Daniel Wolfe, Branch Chief, BARDA CBRN Vaccines, Biomedical Advanced Research And Development Authority